ArticleBritish journal of cancer2014

Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.

H Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.